NCT04922476 - Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 6, 2021

Primary Completion Date

March 4, 2023

Study Completion Date

April 4, 2023

Conditions

Functional Gastrointestinal DisordersFunctional Abdominal Pain

Interventions

DIETARY_SUPPLEMENT

Alflorex®

Each probiotic capsule contains 1 x 10\^9 CFU of B. longum 35624® and corn starch, hydroxypropyl methyl cellulose and magnesium stearate.

Trial Locations (1)

Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago